Fig. 1From: Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMSPatient disposition. All patients enrolled in the study were included in the safety evaluation. All safety analyses were performed on the ITT analysis set. ITT intent-to-treatBack to article page